拜切 2026年季度报告

FORM 10-Q (Mark One) ☑QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the quarterly period ended March31, 2026OR ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the transition period from ____ to ____ Commission file number: 1-13648_______________________________________________________________________________________________________________ Balchem Corporation (Exact name of Registrant as specified in its charter)Maryland13-2578432(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification Number) 5 Paragon Drive, Montvale, NJ 07645(Address of principal executive offices) (Zip Code)Registrant’s telephone number, including area code: (845) 326-5600 Securities registered pursuant to Section 12(b) of the Act: Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the SecuritiesExchange Act of 1934 during the preceding 12 months (or such shorter period that the Registrant was required to file such reports), and(2) has been subject to such filing requirements for the past 90 days. Yes☑No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuantto Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrantwas required to submit such files). Yes☑No☐ Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smallerreporting company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerginggrowth company” in Rule 12b-2 of the Exchange Act. (Check one):Large accelerated filer☑Accelerated filer☐Non-accelerated filer☐Smaller reporting company☐Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period forcomplying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes☐No☑ As of April23, 2026, the registrant had 32,129,836 shares of its Common Stock, $.06 2/3 par value, outstanding. BALCHEM CORPORATIONQUARTERLY REPORT ON FORM 10-QTABLE OF CONTENTS Page No.PART IFINANCIAL INFORMATIONItem 1.Financial Statements (unaudited)Condensed Consolidated Balance Sheets as of March 31, 2026and December 31, 20253Condensed Consolidated Statements of Earnings for the Three Months Ended March 31, 2026 and 20254Condensed Consolidated Statements of Comprehensive Income for the Three Months Ended March 31,2026 and 20255Condensed Consolidated Statements of Changes in Stockholders' Equity for the Three Months EndedMarch 31, 2026 and 20256Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2026 and 20257Notes to Condensed Consolidated Financial Statements8Item 2.Management's Discussion and Analysis of Financial Condition and Results of Operations23Item 3.Quantitative and Qualitative Disclosures About Market Risk29Item 4.Controls and Procedures29PART IIOTHER INFORMATIONItem 1.Legal Proceedings29Item 1A.Risk Factors30Item 2.Unregistered Sales of Equity Securities and Use of Proceeds30Item 5.Other Information31Item 6.Exhibits32SIGNATURE PAGE33 BALCHEM CORPORATIONCondensed Consolidated Statements of Earnings(Dollars in thousands, except per share data)(unaudited) BALCHEM CORPORATIONCondensed Consolidated Statements of Comprehensive Income(Dollars in thousands)(unaudited) See accompanying notes to condensed consolidated financial statements. BALCHEM CORPORATIONCondensed Consolidated Statements of Changes in Stockholders’ EquityFor the Three Months Ended March31, 2026 and 2025(Dollars in thousands, except share and per share data)(Unaudited) BALCHEM CORPORATIONNotes to Condensed Consolidated Financial Statements (Unaudited) (All dollar amounts in thousands, except share and per share data) NOTE 1 – CONDENSED CONSOLIDATED FINANCIAL STATEMENTS The condensed consolidated financial statements presented herein have been prepared in accordance with the accounting policiesdescribed in the December31, 2025 consolidated financial statements, and should be read in conjunction with the consolidatedfinancial statements and notes, which appear in the Annual Report on Form 10-K for the year ended December31, 2025. Thecondensed consolidated financial statements reflect the operations of Balchem Corporation and its subsidiaries (the "Company" or"Balchem"). All intercompany balances and transactions have been eliminated in consolidation. In the opinion of management, the unaudited condensed consolidated financial statements furnished in this Form 10-Q include alladjustments necessary for a f